Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome
Introduction
The periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome, first described as a clinical entity in 1987 [1], belongs to the group of autoinflammatory diseases [2]. This condition is an idiopathic chronic disease of non-hereditary origin, primarily affecting pre-school children, characterized by regularly recurrent fever episodes, lasting for 3–6 days with a remarkable clockwork periodicity of 3–8 weeks in approximately 50% of patients, due to seemingly unprovoked inflammation [2]. By definition, a constellation of cardinal signs (pharyngitis, cervical adenopathy, aphthous stomatitis) and systemic symptoms (headache, abdominal pain, vomiting, malaise, skin rash, etc.) appear in each PFAPA inflammatory attack, which is typically observed in less than 5 year-children who have no sign of respiratory tract infections [3]. At present, no specific biomarkers are available to help the diagnostic evaluation [4]. As in other periodic fever syndromes, there is a marked increase in C-reactive protein (CRP), other acute phase reactants, and white blood cell count [5], which are indicative of a prominent systemic inflammatory response. In children with PFAPA syndrome, these indicators return to normal levels when symptoms subside [5], [6]. Therefore, in order to corroborate the diagnosis, it is necessary to rule out the monogenic periodic fever syndromes that may show overlapping features with PFAPA syndrome [6].
Vitamin D plays an important role in calcium balance, which is largely a function of calcium dietary intake, intestinal absorption, renal excretion, and bone remodeling [7], [8]. More recently, vitamin D has gained attention for a plethora of other crucial benefits, and emerging evidence suggests that vitamin D plays a key-role in immunity regulation [8]. In fact, vitamin D receptors are found on several immune cells, and vitamin D metabolites seem to modulate T cell proliferation and dendritic cell function [9], [10]. Hence, vitamin D deficiency may represent a risk factor for the development of autoimmune and other chronic diseases [8], [11], because of its potential role as an immune-regulatory agent.
Serum 25(OH)D is the most commonly used indicator of vitamin D status, reflecting dietary intake from vitamin D2 (ergocalciferol) and cutaneous synthesis of vitamin D3 (cholecalciferol) [12]. Vitamin D status in PFAPA children has been evaluated in only one study, which did not consider the effects of vitamin D supplementation [13]. The purpose of our study was to assess serum 25(OH)D in children with PFAPA syndrome and evaluate longitudinally the effect of wintertime vitamin D supplementation on the disease course.
Section snippets
Patients and methods
We have consecutively evaluated 25 Italian children (19 males, 6 females, mean age 3.6 ± 0.9 years, range 2.4–5.3 years), after having excluded other causes of recurrent fever. All patients attended the Pediatric Units of different Tuscany Hospitals (Pediatric Unit of Villamarina Hospital, Piombino, Livorno; Pediatric Unit of Mugello's Hospital, Borgo san Lorenzo, Florence; Rheumatology Section, Transition Clinic, University of Florence, Florence; and Health's Sciences Department, Anna Meyer
Statistical analysis
The characteristics of the study population were described through frequency distributions for categorical variables and through means and standard deviations (SDs), medians, and range for continuous variables. The crude association of vitamin D status and the other categorical variables was assessed through chi-square test and Fisher's exact test. The crude association of vitamin D status and continuous variables was assessed through Wilcoxon's rank-sum test and Kruskal–Wallis test, since all
Results
No statistically significant differences were found between patients with PFAPA syndrome and the control group with regards to height (−0.2 ± 0.7 vs 0.1 ± 0.9, p = NS), and body mass index (BMI) SD (0.9 ± 1.3 vs 0.6 ± 1.1, p = NS). The median age at onset of symptoms was 30 months (range: 17–58 months). The mean duration of fever episodes was 4.3 days (95% CI: 3.5–5.3), and the mean duration of intervals between fever episodes was 25.3 days (95% CI: 20.4–30.1). The number of fever episodes per year was 8.9 ±
Discussion
Our data confirm the results of Mahamid et al. who discovered significantly decreased 25(OH)D levels in children with PFAPA syndrome, compared with a control group, showing a correlation between 25(OH)D levels and CRP, and hypothesizing that vitamin D deficiency might be a significant risk factor for PFAPA febrile episode recurrence [13]. Indeed, our patients with PFAPA syndrome displayed reduced serum 25(OH)D levels, apparently related with the number of febrile episodes and CRP, disclosing a
Conclusions
In conclusion, deficient and insufficient vitamin D serum levels have been found in most children with PFAPA syndrome. Hypovitaminosis D can be a significant risk factor for PFAPA episode recurrence. In addition, vitamin D supplementation seems significantly to reduce PFAPA febrile flares and their duration, proving the relevance of vitamin D as a promoter of T cell regulation in this syndrome.
References (20)
- et al.
Syndrome of periodic fever, pharyngitis, and aphthous stomatitis
J. Pediatr.
(1987) - et al.
PFAPA syndrome in children: a meta-analysis on surgical versus medical treatment
Int. J. Pediatr. Otorhinolaryngol.
(2010) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
Am. J. Clin. Nutr.
(2004)Lessons for nutritional science from vitamin D
Am. J. Clin. Nutr.
(1999)- et al.
Vitamin D linked to PFAPA syndrome
Int. J. Pediatr. Otorhinolaryngol.
(2013) Vitamin D regulation of immune function
Vitam. Horm.
(2011)Autoinflammatory syndromes behind the scenes of recurrent fevers in children
Med. Sci. Monit.
(2009)- et al.
PFAPA syndrome
Pediatr. Infect. Dis. J.
(1989) - et al.
Profile of blood cells and inflammatory mediators in periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome
BMC Pediatr.
(2010) - et al.
Differentiating PFAPA syndrome from monogenic periodic fevers
Pediatrics
(2009)
Cited by (54)
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome and Syndrome of Unexplained Recurrent Fevers in Children and Adults
2023, Journal of Allergy and Clinical Immunology: In PracticePeriodic fever syndromes and autoinflammatory diseases
2022, Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic DiseasesThe association between vitamin deficiency and otolaryngologic diseases: A therapeutic target
2020, Medical HypothesesCitation Excerpt :Further, insufficient vitamin D levels were detected in most children with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome, which is an auto-inflammatory disorder distinguished by recurrent fever episodes. Vitamin D supplementation may reduce episodes and duration of PEAPA syndrome due to its regulation role in immunity [42]. Therefore, vitamin D supplementation may be a obtainable and inexpensive method to prevent the recurrence of tonsillopharyngitis and versus the occurrence of PEAPE syndrome.
Vitamin D deficiency as a risk factor for PFAPA syndrome
2019, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :To our knowledge, there are only two studies analysed the link between vitamin D levels and PFAPA syndrome. Both of studies noted a significant correlation between PFAPA and vitamin D deficiency [9,10]. So, further studies with much higher patient number are needed to show whether vitamin D deficiency is a risk factor for PFAPA syndrome.
Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases?
2023, Rheumatology International